Imricor Medical Systems, Inc. (IMR.AX)
AUD 0.96
(-2.05%)
AUD 0.96
(-2.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.99 Million AUD | -10.11% |
| 2022 | -1.52 Million USD | 19.47% |
| 2021 | -1.89 Million AUD | -376.76% |
| 2020 | -397.67 Thousand AUD | -251.59% |
| 2019 | 262.33 Thousand AUD | -80.46% |
| 2018 | 1.34 Million AUD | 137.37% |
| 2017 | 565.59 Thousand AUD | 15.67% |
| 2016 | 488.98 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -270.04 Thousand USD | -44.66% |
| 2024 Q2 | -270.04 Thousand USD | 0.0% |
| 2023 Q1 | -371.24 Thousand USD | -10.87% |
| 2023 FY | -1.68 Million AUD | -10.11% |
| 2023 Q4 | -186.67 Thousand USD | 0.0% |
| 2023 Q3 | -186.67 Thousand USD | 49.72% |
| 2023 Q2 | -371.24 Thousand USD | 0.0% |
| 2022 FY | -1.52 Million USD | 19.47% |
| 2022 Q3 | -334.84 Thousand USD | 21.86% |
| 2022 Q2 | -428.54 Thousand USD | 0.0% |
| 2022 Q1 | -428.54 Thousand USD | 23.07% |
| 2022 Q4 | -334.84 Thousand USD | 0.0% |
| 2021 Q3 | -557.08 Thousand USD | -42.52% |
| 2021 Q4 | -557.08 Thousand USD | 0.0% |
| 2021 Q2 | -390.87 Thousand USD | 0.0% |
| 2021 FY | -1.89 Million AUD | -376.76% |
| 2021 Q1 | -390.87 Thousand USD | -153.87% |
| 2020 Q1 | -44.87 Thousand USD | -143.19% |
| 2020 Q3 | -153.96 Thousand USD | -243.13% |
| 2020 Q2 | -44.87 Thousand USD | 0.0% |
| 2020 Q4 | -153.96 Thousand USD | 0.0% |
| 2020 FY | -397.67 Thousand AUD | -251.59% |
| 2019 Q1 | 27.27 Thousand USD | -82.74% |
| 2019 FY | 262.33 Thousand AUD | -80.46% |
| 2019 Q4 | 103.89 Thousand USD | 0.0% |
| 2019 Q3 | 103.89 Thousand USD | 280.98% |
| 2019 Q2 | 27.27 Thousand USD | -0.0% |
| 2018 Q3 | 158 Thousand USD | -53.96% |
| 2018 Q1 | 343.22 Thousand USD | 0.0% |
| 2018 Q2 | 343.22 Thousand USD | 0.0% |
| 2018 Q4 | 158 Thousand USD | 0.0% |
| 2018 FY | 1.34 Million AUD | 137.37% |
| 2017 FY | 565.59 Thousand AUD | 15.67% |
| 2016 FY | 488.98 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 156.656% |
| Adherium Limited | -640.83 Thousand AUD | -210.984% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 103.691% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 238.713% |
| Anteris Technologies Ltd | 2.51 Million AUD | 179.172% |
| Control Bionics Limited | 3.67 Million AUD | 154.261% |
| CardieX Limited | 10.1 Million AUD | 119.716% |
| Compumedics Limited | 26.06 Million AUD | 107.645% |
| Cochlear Limited | 1.69 Billion AUD | 100.117% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 117.544% |
| Cyclopharm Limited | 4.49 Million AUD | 144.313% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 117.763% |
| Nova Eye Medical Limited | 20.19 Million AUD | 109.869% |
| HeraMED Limited | -504.09 Thousand AUD | -295.341% |
| ImpediMed Limited | 9 Million AUD | 122.131% |
| InhaleRx Limited | 1.2 Million AUD | 265.516% |
| LBT Innovations Limited | -2.91 Million AUD | 31.68% |
| Micro-X Limited | 5.73 Million AUD | 134.738% |
| Neurotech International Limited | -5867.00 AUD | -33867.82% |
| OncoSil Medical Limited | 55.63 Thousand AUD | 3682.276% |
| PolyNovo Limited | 36.08 Million AUD | 105.523% |
| Respiri Limited | 456.91 Thousand AUD | 536.163% |
| SomnoMed Limited | 55.13 Million AUD | 103.615% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 146.509% |
| Uscom Limited | 3.11 Million AUD | 163.963% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | -635.07% |